» Authors » Sai Sakktee Krisna

Sai Sakktee Krisna

Explore the profile of Sai Sakktee Krisna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 227
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roy-Dorval A, Deagle R, Roth F, Raybaud M, Ismailova N, Krisna S, et al.
Front Immunol . 2024 Nov; 15:1493848. PMID: 39497825
Group 2 Innate Lymphoid Cells (ILC2) are critical drivers of both innate and adaptive type 2 immune responses, known to orchestrate processes involved in tissue restoration and wound healing. In...
2.
Prabhu S, Moussa O, Goncalves C, LaPierre J, Chou H, Huang F, et al.
Mol Cancer Ther . 2023 Feb; 22(2):192-204. PMID: 36722142
Aberrant cell-cycle progression is characteristic of melanoma, and CDK4/6 inhibitors, such as palbociclib, are currently being tested for efficacy in this disease. Despite the promising nature of CDK4/6 inhibitors, their...
3.
Mindt B, Krisna S, Duerr C, Mancini M, Richer L, Vidal S, et al.
Front Immunol . 2021 Dec; 12:664218. PMID: 34867937
Group 2 innate lymphoid cells (ILC2s) play a key role in the initiation and orchestration of early type 2 immune responses. Upon tissue damage, ILC2s are activated by alarmins such...
4.
Krisna S, Goncalves C, Gagnon N, Huang F, Plourde D, Miller Jr W, et al.
STAR Protoc . 2021 Jul; 2(3):100627. PMID: 34258591
While isolating immune cells from spleens and lungs is routinely achieved using flow cytometry, it is challenging to isolate viable immune cells from skin. Here, we describe a step-by-step protocol...
5.
Guo Q, Bartish M, Goncalves C, Huang F, Smith-Voudouris J, Krisna S, et al.
Cancer Res . 2021 May; 81(14):3876-3889. PMID: 33975880
Breast cancer diagnosed within 10 years following childbirth is defined as postpartum breast cancer (PPBC) and is highly metastatic. Interactions between immune cells and other stromal cells within the involuting...
6.
Chay W, Kwok L, Tiong W, Krisna S, Lim K, Iyer N, et al.
Int J Gynecol Cancer . 2018 Feb; 28(3):428-436. PMID: 29465505
Background: Mucinous epithelial ovarian cancers (mEOCs) respond poorly to conventional chemotherapy and have a poor prognosis in advanced stages. The genomic landscape for mEOC in the Asian settings is ill...
7.
Yeo T, Tan S, Lim C, Lau D, Chua Y, Krisna S, et al.
Sci Rep . 2016 Mar; 6:22076. PMID: 26924553
Resistance to drug therapy is a major concern in cancer treatment. To probe clones resistant to chemotherapy, the current approach is to conduct pooled cell analysis. However, this can yield...
8.
Tan D, Wang W, Leong H, Sew P, Lau D, Chong F, et al.
BMC Cancer . 2014 Sep; 14:679. PMID: 25234657
Background: Oral tongue squamous cell carcinomas (TSCC) are a unique subset of head and neck cancers with a distinct demographic profile, where up to half of the cases are never...
9.
Khoo B, Warkiani M, Tan D, Bhagat A, Irwin D, Lau D, et al.
PLoS One . 2014 Jul; 9(7):e99409. PMID: 24999991
Background: Circulating tumor cells (CTCs) are cancer cells that can be isolated via liquid biopsy from blood and can be phenotypically and genetically characterized to provide critical information for guiding...
10.
Tan D, Haaland B, Gan J, Tham S, Sinha I, Tan E, et al.
Mol Cancer . 2014 Jan; 13:13. PMID: 24461128
The advent of effective targeted therapeutics has led to increasing emphasis on precise biomarkers for accurate patient stratification. Here, we describe the role of ACK1, a non-receptor tyrosine kinase in...